Published in Science on May 11, 1979
CFS hydroxylase cofactor levels in some neurological diseases. J Neurol Neurosurg Psychiatry (1980) 1.59
SKN-1/Nrf2 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of methylmercury toxicity. Toxicol Sci (2010) 1.11
Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc Natl Acad Sci U S A (1989) 1.11
Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model. Free Radic Biol Med (2010) 1.07
The 1.25 A crystal structure of sepiapterin reductase reveals its binding mode to pterins and brain neurotransmitters. EMBO J (1997) 1.01
α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease. Free Radic Biol Med (2013) 0.99
Crystal structure of the stimulatory complex of GTP cyclohydrolase I and its feedback regulatory protein GFRP. Proc Natl Acad Sci U S A (2002) 0.98
Protein expression in a Drosophila model of Parkinson's disease. J Proteome Res (2007) 0.93
Sepiapterin reductase expression is increased in Parkinson's disease brain tissue. Brain Res (2007) 0.86
Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease. Front Cell Neurosci (2014) 0.85
Autophagy induction by tetrahydrobiopterin deficiency. Autophagy (2011) 0.79
Biopterin levels in the cerebrospinal fluid of patients with PARK8 (I2020T). J Neural Transm (Vienna) (2011) 0.75
Multiple receptors for dopamine. Nature (1979) 5.51
Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med (1999) 5.01
Breast cancer: management of the opposite breast. Oncology (Williston Park) (1988) 4.71
Double-blind study of botulinum toxin in spasmodic torticollis. Lancet (1986) 4.54
Levodopa failure in chronic manganism. Neurology (1994) 3.80
Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo. Biochem Pharmacol (1968) 3.62
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet (1992) 3.30
How coping mediates the effect of optimism on distress: a study of women with early stage breast cancer. J Pers Soc Psychol (1993) 3.18
Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science (2001) 3.18
Problems in assessing contents of metered dose inhalers. BMJ (1993) 3.07
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.06
Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology (1993) 2.86
L-dopa in postencephalitic parkinsonism. Lancet (1969) 2.72
C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis (2000) 2.71
A scoring error in the Mini-Mental State test. Can J Psychiatry (1993) 2.69
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res (1979) 2.61
Bipyridylium quaternary salts and related compounds. V. Pulse radiolysis studies of the reaction of paraquat radical with oxygen. Implications for the mode of action of bipyridyl herbicides. Biochim Biophys Acta (1973) 2.56
Rubredoxin: a new electron transfer protein from Clostridium pasteurianum. Proc Natl Acad Sci U S A (1965) 2.55
Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology (1983) 2.47
Bromocriptine in Parkinsonism. Br Med J (1974) 2.44
Aetiology of Parkinson's disease. Lancet (1984) 2.32
Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover. Ann Neurol (2001) 2.31
Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation (1997) 2.22
Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol (1990) 2.18
Vocal cord paralysis in the Shy-Drager syndrome. J Neurol Neurosurg Psychiatry (1979) 2.04
Diagnostic and therapeutic impact of double-balloon enteroscopy. Endoscopy (2006) 2.03
Definitive diagnosis of breast implant rupture by ultrasonography. Plast Reconstr Surg (1991) 2.03
Auditory-nerve activity in cats with normal and abnormal cochleas. In: Sensorineural hearing loss. Ciba Found Symp (1970) 2.01
Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J Biol Chem (1986) 2.00
The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J Physiol (1967) 1.99
Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology (1999) 1.97
Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features. Cancer (1994) 1.97
Clearing-factor lipase in adipose tissue. A medium in which the enzyme activity of tissue from starved rats increases in vitro. Biochem J (1966) 1.94
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med (1996) 1.93
Reaction time in Parkinson's disease. Brain (1981) 1.92
Cellular response to modulated radiation fields. Phys Med Biol (2007) 1.88
Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology (2004) 1.87
X-linked scapuloperoneal syndrome. J Neurol Neurosurg Psychiatry (1972) 1.87
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology (2004) 1.86
L-dopa in idiopathic parkinsonism. Lancet (1969) 1.86
c-myc regulation during retinoic acid-induced differentiation of F9 cells is posttranscriptional and associated with growth arrest. Mol Cell Biol (1986) 1.85
Noninvasive estimation of the instantaneous first derivative of left ventricular pressure using continuous-wave Doppler echocardiography. Circulation (1991) 1.84
A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet (1998) 1.84
The misuse of antibiotics for treatment of upper respiratory tract infections in children. Pediatrics (1975) 1.82
Hypotension caused by L-dopa. Br Med J (1970) 1.81
Clearing-factor lipase in adipose tissue. Factors influencing the increase in enzyme activity produced on incubation of tissue from starved rats in vitro. Biochem J (1966) 1.79
Positron emission tomography in manganese intoxication. Ann Neurol (1989) 1.78
Effects of dibutyryl-3',5'-cyclic adenosine monophosphage, phosphodiesterase inhibitors and prostaglandin E1 on compound 48-80-induced histamine release from rat peritoneal mast cells in vitro. Biochem Pharmacol (1971) 1.76
Mechanism of dynamic regurgitant orifice area variation in functional mitral regurgitation: physiologic insights from the proximal flow convergence technique. J Am Coll Cardiol (1999) 1.75
Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease. J Am Coll Cardiol (1999) 1.75
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Starch-Ampicillin Agar for the Quantitative Detection of Aeromonas hydrophila. Appl Environ Microbiol (1985) 1.72
Minimum standards for the management of cleft lip and palate: efforts to close the audit loop. Royal College of Surgeons of England. Ann R Coll Surg Engl (1996) 1.72
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol (1997) 1.69
Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis (1992) 1.68
The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic. Ann Neurol (1992) 1.67
Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol (1993) 1.67
The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today (1999) 1.67
Concerns about clinical drug trials. J Clin Psychopharmacol (2000) 1.67
Clearing-factor lipase in adipose tissue. Studies with puromycin and actinomycin. Biochem J (1968) 1.66
Validation of the proximal flow convergence method. Calculation of orifice area in patients with mitral stenosis. Circulation (1993) 1.66
Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation (1997) 1.65
Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment? Lancet (1986) 1.65
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol (2000) 1.65
Cardiovascular reflexes in Parkinsonism. Clin Sci (1971) 1.62
Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Mol Pharmacol (1967) 1.62
Early discharge after mastectomy. A safe way of diminishing hospital costs. Am Surg (1987) 1.61
Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa. Br Med J (1971) 1.60
Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology (1996) 1.60
CFS hydroxylase cofactor levels in some neurological diseases. J Neurol Neurosurg Psychiatry (1980) 1.59
Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol (1997) 1.59
Selegiline in Parkinson's disease. BMJ (1995) 1.58
Characteristics of Clostridium pasteurianum ferredoxin in oxidation-reduction reactions. Biochemistry (1966) 1.58
Proton magnetic resonance study of ferredoxin from Clostridium pasteurianum. Proc Natl Acad Sci U S A (1970) 1.58
Independent regulation of transcription of the two strands of the c-myc gene. Mol Cell Biol (1987) 1.58
Clearing-factor lipase in adipose tissue. Distinction of different states of the enzyme and the possible role of the fat cell in the maintenance of tissue activity. Biochem J (1969) 1.57
Detection of allergen composition and in vivo immunogenicity of depigmented allergoids of Betula alba. Clin Exp Allergy (2008) 1.56
A sensitive and specific double-isotope derivative method for the determination of catecholamines in biological specimens. Am J Med Sci (1968) 1.56
Effects of oral chromium supplementation on the glucose tolerance of elderly human subjects. Metabolism (1968) 1.53
Doppler echocardiographic assessment of progression of aortic regurgitation. Am J Cardiol (1997) 1.52
Lateralized tinnitus studied with functional magnetic resonance imaging: abnormal inferior colliculus activation. J Neurophysiol (2000) 1.52
First x-ray scattering studies on electrostatically levitated metallic liquids: demonstrated influence of local icosahedral order on the nucleation barrier. Phys Rev Lett (2003) 1.51
Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol (2001) 1.51
Structure of rubredoxin: an x-ray study to 2.5 A resolution. J Mol Biol (1970) 1.50
Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med (1996) 1.50
Tryptophan hydroxylation: measurement in pineal gland, brainstem, and carcinoid tumor. Science (1967) 1.49
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism. J Neurol Neurosurg Psychiatry (2000) 1.49
Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet (1987) 1.48
The relationship of mitral annular shape to the diagnosis of mitral valve prolapse. Circulation (1987) 1.48
Motor nerve conduction velocity in peroneal muscular atrophy: evidence for genetic heterogeneity. J Neurol Neurosurg Psychiatry (1974) 1.47
Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett (1990) 1.47
How is difficult asthma managed? Eur Respir J (2006) 1.47
Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow. Ann Neurol (1991) 1.46
Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors. N Engl J Med (1990) 1.46